STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Clinical trials for STAGE IIIC CUTANEOUS MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC CUTANEOUS MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC CUTANEOUS MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in small melanoma study
Disease control CompletedThis early-stage trial tested whether combining a topical cream (imiquimod) with an immunotherapy drug (pembrolizumab) is safe and effective for people with advanced melanoma that has spread. Seven participants with stage IIIB to IV melanoma were enrolled. The study aimed to meas…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New combo therapy shows promise for Hard-to-Treat melanoma
Disease control CompletedThis study tested whether adding bevacizumab to the immunotherapy drug ipilimumab helps people with advanced melanoma that cannot be surgically removed. A total of 169 participants received either ipilimumab alone or with bevacizumab. The goal was to see if the combination improv…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC